Avantor, Inc.
AVTRAPI behind this page
AVTR FY 2025 request
Playground key active
/api/financials?ticker=AVTR&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 6,552.2 | 6,783.6 | -3.4% |
Show Product Lines breakouts |
|||
| Proprietary | 3,448.9 | 3,615.1 | -4.6% |
| Third-party | 3,103.3 | 3,168.5 | -2.1% |
Show Business Segments breakouts |
|||
| Bioscience Production · Operating Segments | 2,152.5 | 2,173.5 | -1.0% |
| Laboratory Solutions · Operating Segments | 4,399.7 | 4,610.1 | -4.6% |
Show Geographic Distribution breakouts |
|||
| All other countries | 3,272.5 | 3,234 | +1.2% |
| US | 3,279.7 | 3,549.6 | -7.6% |
| Cost of Revenue | 4,412.8 | 4,504.3 | -2.0% |
| Gross Profit | 2,139.4 | 2,279.3 | -6.1% |
| Selling, General & Administrative | 1,595.5 | 1,641.1 | -2.8% |
| Asset Impairment Charges | 785 | — | — |
| Gain Loss On Sale Of Business | 5.1 | -446.6 | +101.1% |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Disposed Of By Sale Not Discontinued Operations · Clinical Services | 5.1 | -446.6 | +101.1% |
| Operating Income | -246.2 | 1,084.8 | -122.7% |
| Interest Expense | -169.8 | -218.8 | +22.4% |
| Gains Losses On Extinguishment Of Debt | -4.6 | -10.9 | +57.8% |
Show Debt Instrument breakouts |
|||
| Medium Term Notes · Line Of Credit | -1.1 | -10.9 | +89.9% |
| Other Non-Operating Income (Expense) | -20.7 | -1.2 | -1625.0% |
| Income Before Taxes | -441.3 | 853.9 | -151.7% |
| Income Tax Expense (Benefit) | -88.9 | -142.4 | +37.6% |
| Net Income | -530.2 | 711.5 | -174.5% |
| EPS (Basic) | -0.78 | 1.05 | -174.3% |
| EPS (Diluted) | -0.78 | 1.04 | -175.0% |
| Wtd Avg Shares (Basic) | 680.6 | 679.6 | +0.1% |
| Wtd Avg Shares (Diluted) | 680.6 | 681.9 | -0.2% |
| Comprehensive Income | -363.1 | 596.5 | -160.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 167.1 | -115 | +245.3% |
| Retained Earnings | -530.2 | 711.5 | -174.5% |
| Other Comprehensive Income | 167.1 | -115 | +245.3% |
| Interest Income Operating | 42.2 | 75.1 | -43.8% |
| Net Income Loss Available To Common Stockholders Basic | -530.2 | 711.5 | -174.5% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 365.4 | 261.9 | +39.5% |
| Accounts Receivable | 1,074.6 | 1,034.5 | +3.9% |
| Inventory | 818.2 | 731.5 | +11.9% |
| Other Assets Current | 193 | 118.7 | +62.6% |
| Total Current Assets | 2,451.2 | 2,146.6 | +14.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 766.8 | 708.1 | +8.3% |
Show Geographic Distribution breakouts |
|||
| All other countries | 296.4 | 262.3 | +13.0% |
| US | 470.4 | 445.8 | +5.5% |
| Goodwill | 4,986.9 | 5,539.2 | -10.0% |
Show Business Segments breakouts |
|||
| Bioscience Production | 1,897.6 | 1,888 | +0.5% |
| Laboratory Solutions | 3,089.3 | 3,651.2 | -15.4% |
| Other Non-Current Assets | 396 | 360.4 | +9.9% |
| Total Assets | 11,794.7 | 12,114.5 | -2.6% |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | 5,565 | — | — |
| Operating Lease Right-of-Use Assets | 164.5 | 156.5 | +5.1% |
| Intangible Assets | 3,101.5 | 3,267.9 | -5.1% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 2,742.3 | 2,857.1 | -4.0% |
| Other Intangible Assets | 265.3 | 299.6 | -11.4% |
| Trade Names | 93.9 | 111.2 | -15.6% |
| Other Assets | |||
| Other Intangible Assets Net | 3,193.8 | 3,360.2 | -5.0% |
| Current Liabilities | |||
| Current Portion of Long-Term Debt | 30.8 | 821.1 | -96.2% |
| Accounts Payable | 741.7 | 662.8 | +11.9% |
| Employee Related Liabilities Current | 162.7 | 168.2 | -3.3% |
| Interest Payable Current | 47.3 | 48.6 | -2.7% |
| Other Liabilities Current | 396.4 | 306.8 | +29.2% |
| Total Current Liabilities | 1,378.9 | 2,007.5 | -31.3% |
| Non-Current Liabilities | |||
| Long-Term Debt | 3,915.5 | 3,234.7 | +21.0% |
| Deferred Tax Liabilities | 557.1 | 557.3 | -0.0% |
| Other Non-Current Liabilities | 378.2 | 358.3 | +5.6% |
| Total Liabilities | 6,229.7 | 6,157.8 | +1.2% |
| Long-Term Debt | 3,946.3 | 4,055.8 | -2.7% |
| Operating Lease Liabilities | 152 | 143.2 | +6.1% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 3,984.8 | 3,937.7 | +1.2% |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | 3,984.8 | — | — |
| Treasury Stock Common Value | -75.7 | — | — |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | -75.7 | — | — |
| Retained Earnings | 1,672.8 | 2,203 | -24.1% |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | 1,672.8 | — | — |
| Accumulated Other Comprehensive Income | -16.9 | -184 | +90.8% |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | -16.9 | — | — |
| Total Stockholders' Equity | 5,565 | 5,956.7 | -6.6% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 14.1 | -6.8 | +307.4% |
| Accumulated Other Comprehensive Income | -16.9 | -184 | +90.8% |
| Accumulated Translation Adjustment | -31 | -177.4 | +82.5% |
| Common Stock Including Additional Paid In Capital | 3,984.8 | 3,937.7 | +1.2% |
| Retained Earnings | 1,672.8 | 2,203 | -24.1% |
| Treasury Stock Common | -75.7 | — | — |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | 5,565 | — | — |
| Total Liabilities & Equity | 11,794.7 | 12,114.5 | -2.6% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -530.2 | 711.5 | -174.5% |
| Depreciation And Amortization | 410.2 | 405.5 | +1.2% |
Show Business Segments breakouts |
|||
| Bioscience Production | 204.4 | 192.7 | +6.1% |
| Laboratory Solutions | 205.8 | 212.8 | -3.3% |
| Stock-Based Compensation | 46.4 | 46.8 | -0.9% |
| Restructuring Reserve Settled Without Cash2 | 3.2 | 16.9 | -81.1% |
| Provision For Accounts Receivable And Inventory | 63.7 | 75.1 | -15.2% |
| Deferred Income Taxes | 7.7 | -46.9 | +116.4% |
| Amortization of Financing Costs | 8.5 | 11.2 | -24.1% |
| Foreign Currency Transaction Gain Loss Before Tax | 1.7 | -0.3 | +666.7% |
| Pension Termination Charges | 18.1 | 9.3 | +94.6% |
Show Retirement Plan Type breakouts |
|||
| Pension Plans Defined Benefit · US | 16.3 | 9.3 | +75.3% |
| Change in Accounts Receivable | 13.6 | 45.9 | -70.4% |
| Change in Inventory | -109.4 | -18.5 | -491.4% |
| Increase Decrease In Accounts Payable Trade | 42.4 | 59.6 | -28.9% |
| Increase Decrease In Interest Payable Net | -1.3 | -1.6 | +18.8% |
| Increase Decrease In Other Operating Capital Net | -144.2 | -37.7 | -282.5% |
| Other Non-Cash Items | -1.3 | -0.3 | -333.3% |
| Net Cash from Operations | 623.8 | 840.8 | -25.8% |
| Investing Activities | |||
| Capital Expenditures | -128.8 | -148.8 | +13.4% |
| Other Investing Activities | -1.7 | 2.5 | -168.0% |
| Net Cash from Investing | -130.5 | 438.9 | -129.7% |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | 0.5 | -60.6 | +100.8% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 1,107.6 | — | — |
| Repayments Of Long Term Debt | -1,426.3 | -1,341.8 | -6.3% |
| Payments Of Financing Costs | -15.1 | — | — |
| Proceeds From Stock Options Exercised | 5.1 | 69.2 | -92.6% |
| Tax Withholding for Share Compensation | -5.6 | -8.6 | +34.9% |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | -5.6 | -8.6 | +34.9% |
| Share Repurchases | -75.1 | — | — |
| Net Cash from Financing | -409.4 | -1,281.2 | +68.0% |
Show Legal Entity breakouts |
|||
| Unconsolidated Avantor, Inc | -0.5 | 60.6 | -100.8% |
| Debt Repayments | 449.4 | 526.4 | -14.6% |
Show Debt Instrument breakouts |
|||
| Medium Term Notes · USD | 80.8 | 690 | -88.3% |
| Supplemental | |||
| Income Taxes Paid | 145 | 247.8 | -41.5% |
| Interest Paid | 161.3 | 211 | -23.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 19.7 | -21.5 | +191.6% |
| Net Change in Cash | 103.6 | -23 | +550.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 368.3 | 264.7 | +39.1% |
Values in millions USD. Source: SEC EDGAR 10-K filing.